Join @scPharmaceuticals (#SCPH) for a KOL webinar on Tuesday, October 22 at 1:00 p.m. ET, for a nephrologist’s perspective on the use of FUROSCIX for treating fluid overload in heart failure and the potential use in chronic kidney disease (CKD). The event will feature Dr. Michael Aaronson, MD (Lincoln Nephrology and Hypertension, Lincoln, NE). Register here: https://lnkd.in/em5sMgqU
scPharmaceuticals
Pharmaceutical Manufacturing
Burlington, MA 4,914 followers
Focused on exploring, developing and commercializing innovative solutions to enhance the potential of outpatient care.
About us
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.
- Website
-
http://scpharmaceuticals.com/
External link for scPharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Burlington, MA
- Type
- Public Company
- Founded
- 2014
- Specialties
- Improving Diuresis in Heart Failure, Next Generation OPAT, Medical Countermeasure Solutions, and Heart Failure
Locations
-
Primary
Get directions
25 Mall Road, Suite 203
Burlington, MA 01803, US